Evidence map›Paper›PMID 33655382›Full record

ReviewCurrent cardiology reports2021

Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease.

Timir K Paul, Mamas A Mamas, Madhan Shanmugasundaram, Harsha S Nagarajarao, Chandra P Ojha, Hani Jneid, Gautam Kumar, Christopher J White

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Risk Factors of Cardiac Death for Elderly Patients with Severe Chronic Kidney Disease after Percutaneous Coronary Intervention.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 3 countries.

Timir K PaulDepartment of Medicine, Division of Cardiology, East Tennessee State University, 329 N State of Franklin Rd, Johnson City, TN, 37604, USA. pault@etsu.edu.
Mamas A MamasKeele Cardiovascular Research Group, Keele University, Stoke on Trent, UK.
Madhan ShanmugasundaramUniversity of Arizona Health Sciences Center, Tucson, AZ, USA.
Harsha S NagarajaraoTexas Tech University of Health Sciences, El Paso, TX, USA.
Chandra P OjhaTexas Tech University of Health Sciences, El Paso, TX, USA.
Hani JneidDivision of Cardiology, Baylor College of Medicine, Houston, TX, USA.
Gautam KumarEmory University School of Medicine, Atlanta, GA, USA.
Christopher J WhiteDepartment of Cardiovascular Diseases, The Ochsner Clinical School, University of Queensland, Brisbane, Australia.
Texas Tech University · USBaylor College of Medicine · USEast Tennessee State University · USEmory University · USKeele University · GBUniversity of Arizona · USUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis article reviews the evidence on optimal medical therapy (OMT) versus coronary revascularization in patients with stable ischemic heart disease (SIHD) and advanced chronic kidney disease (CKD). RECENT

findingsA post hoc analysis of the COURAGE trial in patients with SIHD and CKD showed no difference in freedom from angina, death, and nonfatal myocardial infarction (MI) between OMT and percutaneous intervention plus OMT compared with patients without CKD. The ISCHEMIA-CKD trial of 777 patients with advanced CKD revealed no difference in cumulative incidence of death or nonfatal MI at 3 years between OMT and revascularization but the composite of death or new dialysis was higher in the invasive arm. Additionally, there were no significant or sustained benefits in related to angina-related health status in invasive versus conservative strategy. An initial revascularization strategy does not reduce mortality or MI or relieve angina symptoms in patients with SIHD and advanced CKD.

Indexed as

Coronary Artery DiseaseMyocardial IschemiaPercutaneous Coronary InterventionRenal Insufficiency, ChronicAngina PectorisCoronary Artery BypassHumansTreatment OutcomeAdvanced chronic kidney diseaseCoronary artery bypass graftOptimal medical therapyPercutaneous coronary interventionRevascularizationStable ischemic heart disease

Identifiers

PMID33655382
OpenAlexW3134107156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.